Skip to content

Study Of Chittodvega(Anxiety) in Post Covid patientsâ??

An Etiopathological Study Of Chittodvega(Anxiety) in Post Covid patients and Therapeutic trial with Saraswat Churna and Satvavajyaya Chikitsa â??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040561
Enrollment
60
Registered
2022-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F419- Anxiety disorder, unspecified Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

NATIONAL INSTITUTE OF AYURVEDA DEMEED TO BE UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Moderate to severe patients who have clinically recovered from COVID 19. Patients of age group above 18 years of both sexes.

Exclusion criteria

Exclusion criteria: 1. Patients with the history of psychiatric disorders, critical illness. 2. Pregnant woman. 3. Patients below 18years.

Design outcomes

Primary

MeasureTime frame
To asses the changes in post covid anxiety score on the basis of Hamilton Anxiety Rating Scale before and after intervention i.e b/w 0 and day 60. Timepoint: 8 WEEKS

Secondary

MeasureTime frame
To evaluate the efficacy of Saraswat Churna and Satvavajya Chikitsa the management of post covid anxiety disorders.Timepoint: 2months

Countries

India

Contacts

Public ContactPRIYANKA MEENA

national institute of ayurveda , deemed to be university

drsksm31@rediffmail.com9414361874

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026